Contract Pharmacal Corp manufactures and packages vitamins, minerals, supplements, and OTC drugs for pharmaceutical companies, CPG brands, and retailers globally. The tech stack reflects a manufacturing-heavy operation: PLC, HMI, CMMS, and analytical instruments (HPLC, UPLC, FT-IR) dominate, with no cloud-native or modern software adoption visible. Pain-point clustering around equipment downtime and reliability, combined with active hiring in manufacturing and serialization projects, suggests the company is investing in operational stability and regulatory compliance over digital transformation.
Contract Pharmacal Corp is a privately held CDMO operating nearly one million square feet in Hauppauge, New York. Since 1971, the company has developed approximately 100 new products annually and operates manufacturing capacity to support over 25 billion doses per year. The business spans formulation development, commercial manufacturing, packaging, and analytical testing for more than 60 global partners—ranging from top-tier pharmaceutical companies to retailers and wholesalers. The workforce of approximately 1,250 is employee-owned. Current project focus includes oral solid dosage formulation, stability method development, equipment qualification, and serialized packaging compliance.
CPC can manufacture more than 25 billion doses annually across its Hauppauge, New York facilities, which span almost one million square feet.
CPC's tech stack includes HPLC, UPLC, and FT-IR instruments for analytical testing, supported by PLC controls and HMI systems for manufacturing operations.
Other companies in the same industry, closest in size